Insider Transactions in Q2 2019 at Prevail Therapeutics Inc. (PRVL)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2019
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
882,352
+6.0%
|
$14,999,984
$17.0 P/Share
|
|
Jun 24
2019
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
10,510,111
+44.82%
|
-
|